United States was Glaukos’s largest region in fiscal 2025, bringing in $375.04M of $507.44M (74%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $203.24M | $219.40M | $270.09M | $375.04M | ||||||
| International | $79.62M | $95.32M | $113.39M | $132.40M | ||||||
| Total | $282.86M | $314.71M | $383.48M | $507.44M |
Glaukos brought in $507.44M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 32.3% from $383.48M in fiscal 2024. United States was the largest at $375.04M (73.9%), ahead of International at $132.40M (26.1%).
Compared with fiscal 2024, United States grew 38.9% to $375.04M and International grew 16.8% to $132.40M. From fiscal 2022 to 2025, combined revenue from these regions grew from $282.86M to $507.44M, a compound annual growth rate of 21.5%. United States' share of the total rose from 71.9% to 73.9%.
Glaucoma was Glaukos’s largest product and service line in fiscal 2025, bringing in $421.07M of $507.44M (83%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Glaucoma | $214.24M | $237.04M | $303.28M | $421.07M | |||||
| Corneal Health | $68.62M | $77.67M | $80.21M | $86.37M | |||||
| Total | $282.86M | $314.71M | $383.48M | $507.44M |
Glaukos brought in $507.44M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 32.3% from $383.48M in fiscal 2024. Glaucoma was the largest at $421.07M (83.0%), ahead of Corneal Health at $86.37M (17.0%).
Compared with fiscal 2024, Glaucoma grew 38.8% to $421.07M and Corneal Health grew 7.7% to $86.37M. From fiscal 2022 to 2025, combined revenue from these lines grew from $282.86M to $507.44M, a compound annual growth rate of 21.5%. Glaucoma's share of the total rose from 75.7% to 83.0%.
Glaukos (GKOS) reports its revenue by geography and by product and service. In fiscal 2025, United States was its largest region, bringing in $375.04M (73.9% of the total), followed by International at $132.40M (26.1%).
United States was Glaukos' largest region in fiscal 2025, bringing in $375.04M, or 73.9% of the $507.44M total across its two regions.
Glaucoma was Glaukos' largest product and service line in fiscal 2025, bringing in $421.07M, or 83.0% of the $507.44M total across its two product and service lines.
United States grew faster than International in fiscal 2025, up 38.9% from $270.09M to $375.04M. International grew 16.8% to $132.40M.
Every figure comes from Glaukos' annual financial filings, as reported. Each line keeps the name Glaukos gives it, and years follow its fiscal calendar.
Glaukos' revenue by geography goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.